Troglitazone
-
Catalog number1696-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name(±)-5-[4-[(6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]benzyl]-2,4-thiazolidinedione
-
DescriptionAn antidiabetic thiazolidinedione (TDZ) drug with anti-inflammatory and anti-tumor activities. A potent and selective PPARɣ agonist. The EC₅₀ values for transactivation of human and murine PPARɣ in a cell-based assay are 0.55 and 0.78 µM, respectively.
-
CAS Number97322-87-7
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₄H₂₇NO₅S
-
Molecular Weight441.54
-
Cell PermeableYes
-
Purity≥95% by HPLC
-
SolubilitiesDMSO (25 mg/ml) or Ethanol (25 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA selective PPARɣ agonist
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
MDL NumberMFCD00878416
-
PubChem CID5591
-
SMILESCC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O
-
InChiInChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28)
-
InChi KeyGXPHKUHSUJUWKP-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameTroglitazone
-
Alternative nameTroglitazone
-